Ilumina joins a collaborative project to decode the COVID-19 immune response
Illumina, have today announced that they are part of a new collaboration with Adaptive Biotechnologies Corp., Microsoft, LabCorp and Providence Health & Services to decode the COVID-19 immune response and to provide open access to data from the virtual clinical trial starting in April 2020.
Campus research, innovation and engagement recognised at the 2022 Cambridge Independent Science and Technology Awards
The Cambridge Independent Science and Technology Awards took place on Wednesday evening at the Hinxton Hall Conference Centre. Campus teams, ...
13 May 2022Learn more
Birmingham 2022 Queen’s Baton Relay to visit Wellcome Genome Campus as full England route revealed
11 May 2022Learn more